Arbutus Biopharma Corp. (ABUS) Stock on a Consistent Rise, Here’s Why
Arbutus Biopharma Corp. (ABUS), a biopharmaceutical company, has gained an increase of 2.39% in aftermarket trading session. Consequently, ABUS is trading at $4.72 at the time of the writing. On Wednesday, ABUS closed the day at $4.61 after soaring 44.06% during the mid-day session. The mammoth increase was attributable to the positive preliminary data depicting safety of […]
Arbutus Biopharma Corp. (ABUS) Stock on a Consistent Rise, Here’s Why Read More »